GALENA BIOPHARMA INC's ticker is GALEXXXX and the CUSIP is 363256108. A total of 62 filers reported holding GALENA BIOPHARMA INC in Q2 2013. The put-call ratio across all filers is 0.58 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $48,000 | -42.9% | 137,500 | -23.9% | 0.00% | – |
| Q2 2016 | $84,000 | -42.5% | 180,800 | +68.5% | 0.00% | – |
| Q1 2016 | $146,000 | -28.8% | 107,300 | -23.2% | 0.00% | – |
| Q4 2015 | $205,000 | -7.2% | 139,700 | 0.0% | 0.00% | – |
| Q3 2015 | $221,000 | -6.8% | 139,700 | 0.0% | 0.00% | – |
| Q2 2015 | $237,000 | +106.1% | 139,700 | +69.5% | 0.00% | – |
| Q1 2015 | $115,000 | -23.3% | 82,400 | -17.2% | 0.00% | – |
| Q4 2014 | $150,000 | -26.8% | 99,500 | 0.0% | 0.00% | – |
| Q3 2014 | $205,000 | -40.6% | 99,500 | -11.9% | 0.00% | – |
| Q2 2014 | $345,000 | -11.1% | 112,900 | -27.3% | 0.00% | – |
| Q1 2014 | $388,000 | +1008.6% | 155,335 | +2077.1% | 0.00% | – |
| Q4 2013 | $35,000 | -31.4% | 7,135 | -68.5% | 0.00% | – |
| Q3 2013 | $51,000 | -42.0% | 22,635 | -42.7% | 0.00% | – |
| Q2 2013 | $88,000 | – | 39,496 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 375,000 | $855,000 | 0.93% |
| HIGHLAND CAPITAL MANAGEMENT LP | 800,000 | $1,824,000 | 0.12% |
| Alyeska Investment Group, L.P. | 780,000 | $1,778,000 | 0.07% |
| KMS FINANCIAL SERVICES, INC | 119,500 | $272,000 | 0.07% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 539,150 | $1,229,000 | 0.04% |
| DUMONT & BLAKE INVESTMENT ADVISORS LLC | 25,100 | $57,000 | 0.03% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 349,400 | $793,000,000 | 0.02% |
| COMPTON CAPITAL MANAGEMENT INC /RI | 12,000 | $27,000 | 0.02% |
| Diversified Trust Co | 40,000 | $91,000 | 0.01% |
| PITTENGER & ANDERSON INC | 18,000 | $41,000 | 0.01% |